GlycoPath has received an STTR grant from the National Cancer Institute to utilize their patent-pending GlycoTyper™ technology for the development of a biomarker panel...
WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a state-of-the-art novel...
Rakuten Medical, Inc. has elected to discontinue use of the name "Illuminox," and to start using a new, evolved name "Alluminox™" for our proprietary,...
The U.S. Food and Drug Administration announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef...
Southern Company and Black Enterprise will partner to present Investing in Tomorrow, a virtual event bringing together Georgia's Senator Raphael Warnock; Georgia Power's Chairman,...
